Finzati - Logo
TAK logo

Takeda Pharmaceutical Company Limited

TAK • Drug Manufacturers - Specialty & Generic
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$54.88B
Growth
6.5%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 7.4%Positive free cash flow · 256.72Consistent free cash flow · 5/5Manageable debt level · 0.63Expensive earnings multiple · 45.54
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$54.88B
52W Range12.99 - 18.90
Beta0.09
Gross Margin51.06%
Oper. Margin11.99%
Profit Margin4.26%
Debt/Eq0.63
Current Ratio1.27
Quick Ratio0.70
Revenue 5Y6.51%

Investment DNA

How strong this company looks for long-term investors

65
out of 100
Business Quality
Margins, moat, returns
50/100
Financial Strength
Debt, cash, stability
50/100
Growth Potential
Revenue and expansion
51/100
Price Attractiveness
Cheap or expensive today
74/100
Why this score▼
Positive revenue growth · 7.4%Positive free cash flow · 256.72Consistent free cash flow · 5/5Manageable debt level · 0.63Expensive earnings multiple · 45.54
Analyst view
No analyst data available now.

Company Overview

IPO: 1/5/2010
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 1.19
Debt / Equity i: 0.63
Operating Margin: 11.99%
Net Margin: 4.26%
ROE i: -
ROIC: -

Financial Health

Score10 / 20
Debt / Equity: 0.63
Current Ratio: 1.27
Quick Ratio: 0.70
Status: Moderate

Warnings

  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Furuta Milano
Transaction: 07/10/2026
SELL
Change
-16,619
Price
Not reported
Filing
07/06/2026
Type
SELL
Miyabashira Asuka
Transaction: 07/10/2026
SELL
Change
-1,022
Price
Not reported
Filing
07/06/2026
Type
SELL
Tsusaka Miki
Transaction: 07/10/2026
SELL
Change
-2,152
Price
Not reported
Filing
07/06/2026
Type
SELL